Biotechnologies from health...to beauty
March 9, 2015
Thien Nguyen, director of the dermo-cosmetic biotechnology research unit at Pierre Fabre, presented the potential synergies to be found between pharmaceutical research and cosmetic research, giving two examples of dermo-cosmetic active ingredients produced using biotechnology.
Biotechnologies from health...
At Pierre Fabre, we have been using biotechnologies in our medical research since the 1970s, when we launched an immunostimulant for preventing respiratory conditions in children. Buoyed with the success of this product, Mr. Fabre decided to create an R&D center dedicated to immunology and biotechnologies, which opened in
The use of biotechnologies for dermo-cosmetics dates back to the 1990s with the development by Pierre Fabre of anti-aging ingredients extracted from blue-green algae for its Galénic brand. This led to the creation of a dedicated structure, combining the biotechnologies unit from the Pierre Fabre Dermo-Cosmetics R&D center in
A biotechnological active ingredient extracted from Avène thermal spring water
The research produced by these three laboratories was used to isolate and identify the biological signature of Avène thermal spring water: Aqua Dolomiae, a unique microflora with immunomodulatory and anti-inflammatory properties. The active substances obtained from this microflora were incorporated into a range of Eau Thermale Avène products designed for the most sensitive and driest skin, XéraCalm A.D.
Native argan cell cultures for Galénic
At the same time, the biotechnology unit at
With over 40 years' experience in working with biotechnologies, Pierre Fabre is imagining and developing the dermo-cosmetic care of tomorrow.